Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Study just says in addition to SoC.

https://clinicaltrials.gov/ct2/show/study/NCT04784897?term=Brilacidin&draw=2&rank=2

Treatment period (Day 1-3 with potential to expand to Day 4-5): Randomized subjects will receive blinded study treatment once daily for 3 days by IV infusion, in addition to SoC.

Message in reply to:
Minnie, isn't P2 designed so that B is compared to the FDA designated SOC?